References
1
Venuti MC.
Comprehensive Medicinal Chemistry
Vol. 3:
Emmett JC.
Pergamon Press;
New York:
1990.
p.749-750
2
Kulikov VI.
Muzya GI.
Biochemistry
1998,
63:
47
3
Calvo L.
González Ortega A.
Sañudo MC.
Synthesis
2002,
2450
4
Synthesis of 5,7-Dimethyl-1
H
,3
H
-pyrrolo[1,2-
c
]thiazole-6-carbonitrile (
5).
To a magnetically stirred solution of 3 (1.08 g, 4.48 mmol) in anhyd THF (50 mL) was added dropwise MeLi (4.48 mL 1.5 M, 6.72 mmol) under nitrogen at -40 °C. At the end of the reaction, monitored by TLC, the mixture was hydrolyzed. The organic layer was decanted, washed with H2O, dried (MgSO4) and evaporated. The carbonyl intermediate 4 was not isolated and the concentrate underwent cyclization treatment. The previously mentioned intermediate (ca. 4.00 mmol) and silica gel (5 × w/w) in CHCl3 (50 mL) was heated in a rotatory evaporator, slowly distilling the solvent. The silica gel was filtered off and washed thoroughly with hot acetone. The solvent was removed in vacuo, and the concentrate was chromatographed (silica gel; CH2Cl2, R
f
= 0.53; 80%). Colorless solid, mp 150 °C. IR (KBr): 3436, 2920, 2214, 1596, 1527, 1420, 1384, 1276, 1181, 922, 898 cm-1. 1H NMR (300 MHz, CDCl3): δ = 4.83 (s, 2 H, N-CH2-S), 3.91 (s, 2 H, S-CH2), 2.30 (s, 3 H, -C=C-CH3), 2.03 [s, 3 H, =C(CH3)-N]. 13C NMR (75 MHz, CDCl3): δ = 132.25 [=C(CH3)-N], 130.21 (-C=C-CH3), 116.41 (N≡C), 112.34 (NC-C), 95.97 (-C=C-CH3), 46.91 (S-CH2-N), 27.34 (S-CH2), 11.33 (-C=C-CH3), 10.00 [=C(CH3)-N]. MS (EI): m/z (%) = 178 (85) [M+], 133 (100). Anal. Calcd for C9H10N2S: C, 60.64; H, 5.65; N, 15.72. Found: C, 60.77;
H, 5.67; N, 15.69.
5
Preparation of Intermediate (
R
)-3-(2-Cyano-1-methylvinyl)-
N
-methoxy-
N
-methylthiazolidine-4-carboxamide (
3)
.
A mixture of enaminonitrile 1 (0.32 g, 3.89 mmol) and (R)-N-methoxy-N-methylthiazolidine-4-carboxamide (hydrobromide derivative) (2.00 g, 7.78 mmol) in MeOH (10 mL) was stirred at r.t. for 3 h. At the end of the reaction, monitored by TLC, the solution was concentrated in vacuo, and the residue was dissolved in CH2Cl2-H2O (1:1, 25 mL). The aqueous layer was extracted with CH2Cl2 (2 × 20 mL) and the combined organic layers were dried (MgSO4) and evaporated to dryness. The residue was chromatographed (silica gel, CH2Cl2-Et2O, 20:1, Rf = 0.30; 62%). Colorless solid, mp 87 °C. IR (KBr): 3312, 3135, 3076, 2937, 2195, 1669, 1583, 1514, 1417, 1386, 1283, 1090, 889 cm-1. 1H NMR (300 MHz, CDCl3): δ = 4.88 (dd, J = 7.4 and 3.5 Hz, 1 H, CH-CO), 4.48 (s, 2 H, N-CH2-S), 3.79 (s, 1 H, HC=), 3.77 (s, 3 H, N-OCH3), 3.45 (dd, J = 11.8 and 7.4 Hz, 1 H, S-CHH), 3.22 (s, 3 H, N-CH3), 3.14 (dd, J = 11.8 and 3.5 Hz, 1 H, S-CHH), 2.21 (s, 3 H, =C-CH3). 13C NMR (75 MHz, CDCl3): δ = 169.66 (C=O), 158.03 (=C), 120.81 (C≡N), 65.16 (=CH), 61.31 (N-OCH3), 60.98 (CH-CO) 51.09 (N-CH2-S), 33.38 (S-CH2), 32.20 (N-CH3), 19.20 (CH3). MS (EI): m/z (%) = 241 (26) [M+], 116 (100). [α]D
20 -79.8 (c 0.29, CHCl3). Anal. Calcd for C10H15N3O2S: C, 49.77; H, 6.27; N, 17.41. Found: C, 49.68; H, 6.28; N, 17.43.
6
Synthesis of (
R
)-6-Cyano-
N
-methoxy-
N
,5-dimethyl-2,3,4,7-tetrahydro-1,4-thiazepine-3-carboxamide (
6).
By a procedure analogous to the previous one starting from 1 (0.16 g, 1.94 mmol) and 2 (1 g, 3.89 mmol), in 25 mL of MeCN (reflux for 2.5 h), compound 6 was obtained (51%). Oil, Rf = 0.48 [CH2Cl2-Et2O (20:1)]. IR (film): 3343, 2937, 2361, 2183, 1667, 1604, 1430, 1392, 1178, 1000 cm-1. 1H NMR (300 MHz, CDCl3): δ = 5.23 (d, J = 3.8 Hz, 1 H, NH), 4.88 (ddd, J = 11.0, 3.8 and 2.8 Hz, 1 H, CH-CO), 4.16 (d, J = 16.3 Hz, 1 H, =C-CHH), 3.77 (s, 3 H, N-OCH3), 3.27 (dd, J = 12.4 and 2.8 Hz, 1 H, S-CHH), 3.26 (s, 3 H, N-CH3), 2.93 (d, J = 16.3 Hz, 1 H, =C-CHH), 2.85 (dd, J = 12.4 and 11.0 Hz, 1 H, S-CHH), 2.08 (s, 3 H, CH3). 13C NMR (75 MHz, CDCl3): δ = 169.41 (C=O), 158.33 (=C), 122.62 (C≡N), 77.21 (NC-C=), 61.65 (N-OCH3), 55.43 (CH-CO), 33.41 (S-CH2-CH), 32.48 (N-CH3), 27.88 (S-CH2-C=), 22.17 (CH3). MS (EI): m/z (%) = 241 (3) [M+], 42 (100). [α]D
20 +72.7 (c 0.98, CHCl3). Anal. Calcd for C10H15N3O2S: C, 49.77; H, 6.27; N, 17.41. Found: C, 49.92; H, 6.26; N, 17.38.
7
Van den Hoven BG.
Alper H.
J. Am. Chem. Soc.
2001,
123:
1017
8a
Mushkalo LK.
Lanovaya ZI.
Ukr. Khim. Zh.
1955,
21:
631
8b
Mushkalo LK.
Shokol ZI.
Zh. Obshch. Khim.
1960,
30:
1023
8c
Hankovszky OH.
Hideg K.
Lloyd D.
J. Chem. Soc., Perkin Trans. 1
1974,
14:
1619
9
Donati D.
Marchioro C.
Tamburini B.
Ursini A.
Org. Prep. Proced. Int.
1992,
24:
48
10a
Minkin VI.
Garnovskii AD.
Elguero J.
Katritzky AR.
Denisko OV.
Adv. Heterocycl. Chem.
2000,
76:
258
10b
Lázar L.
Fülop F.
Eur. J. Org. Chem.
2003,
3025
10c
Fernández X.
Duñach E.
Tetrahedron: Asymmetry
2001,
12:
1279
11a
Lue P.
Greenhill JV.
Adv. Heterocycl. Chem.
1997,
67:
269
11b
Lue P.
Greenhill JV.
Adv. Heterocycl. Chem.
1997,
67:
274
12
Kuckländer U.
The Chemistry of Enamines, In The Chemistry of Functional Groups
Part 1:
Rappoport Z.
Wiley;
New York:
1994.
p.530-531
13
Jephote VJ.
Jowett IC.
John DI.
Edwards PD.
Luk K.
Slawin AM.
Williams DJ.
J. Chem. Soc., Perkin Trans. 1
1986,
12:
2187
14
Lambert JB.
Majchrzak MW.
J. Am. Chem. Soc.
1980,
102:
3588
15
Alberola A.
González Ortega A.
Sábada ML.
Sañudo MC.
Tetrahedron
1999,
55:
6555
16
Reaction of (
R
)-6-Cyano-
N
-methoxy-
N
,5-dimethyl-2,3,4,7-tetrahydro-1,4-thiazepine-3-carboxamide (
6) with Organometallic Compounds. Synthesis of 8-Hydroxy-7-methyl-3-thia-6-azabicyclo[3.2.1]oct-6-ene-1-carbonitriles 12, General Procedure:
To a magnetically stirred solution of amide 6 (0.54 g, 2.22 mmol) in dry THF (35 mL) the organometallic compound was added dropwise under nitrogen (see Table
[1]
). At the end of the reaction, the mixture was hydrolyzed. The organic layer was decanted, washed with H2O, dried (MgSO4) and evaporated. The concentrate and silica gel (5 × w/w) in 50 mL of CHCl3 were heated in a rotary evaporator, slowly distilling the solvent. The silica gel was filtered off and washed thoroughly with hot acetone. The solvent was removed in vacuo, and the concentrate was chromato-graphed on silica gel using CH2Cl2-THF (10:1) as eluent (compounds 12a,b) or recrystallized from EtOH (compounds 12c,d). Representative compounds:
8-Hydroxy-7-methyl-3-thia-6-azabicyclo[3.2.1]oct-6-ene-1-carbonitrile (
12a): Yield 39%. R
f
= 0.23 [CH2Cl2-THF (10:1)]. Colorless solid, mp 178 °C. IR (KBr): 3435, 3082, 2944, 2864, 2232, 1647, 1434, 1382, 1244, 1161, 1096, 979 cm-1. 1H NMR (300 MHz, DMSO-d
6): δ = 6.51 (br s, 1 H, OH), 4.28 (d, J = 5.9 Hz, 1 H, CH-OH), 4.07-4.04 (m, 1 H, =N-CH), 3.02 (d, J = 12.2 Hz, 1 H, CN-C-CHH), 2.94 (d, J = 12.7 Hz, 1 H, S-CHH), 2.53 (d, J = 12.2 Hz, 1 H, CN-C-CHH), 2.17 (s, 3 H, CH3), 2.10 (dd, J = 12.7 and 4.2 Hz, 1 H, S-CHH). 13C NMR (75 MHz, DMSO-d
6): δ = 168.64 (CH3-C=N), 119.71 (C≡N), 73.44 (CH-OH), 64.55 (N-CH), 49.66 (CN-C), 20.00 (S-CH2-), 19.72 (NC-C-
CH2-), 17.84 (CH3). Anal. Calcd for C8H10N2OS: C, 52.72; H, 5.53; N, 15.37. Found: C, 52.54; H, 5.52; N, 15.42.
8-Ethyl-8-hydroxy-7-methyl-3-thia-6-aza-bicyclo[3.2.1]oct-6-ene-1-carbonitrile (
12c): Yield 63%. Colorless solid, mp 161 °C. IR (KBr): 3408, 3095, 2942, 2852, 2236, 1638, 1428, 1385, 1283, 1167, 1015, 928 cm-1. 1H NMR (300 MHz, CDCl3): δ = 4.20 (d, J = 3.2 Hz, 1 H, CH), 3.39 (d, J = 12.4 Hz, 1 H, CN-C-CHH), 3.23 (d, J = 12.5 Hz, 1 H, S-CHH), 2.40 (br s, 1 H, OH), 2.37 (d, J = 12.4 Hz, 1 H, CN-C-CHH), 2.35 (dd, J = 12.5 and 3.2 Hz, 1 H, S-CHH), 2.29 (s, 3 H, =C-CH3), 1.76 (m, J = 7.4 Hz, 2 H, CH
2-CH3), 0.98 (t, J = 7.4 Hz, 3 H, CH2-CH
3). 13C NMR (75 MHz, CDCl3): δ = 170.73 (CH3-C=N), 117.28 (C≡N), 80.78 (C-OH), 66.40 (CH), 55.97 (CN-C), 29.68 (CH2-CH3), 24.20 (S-CH2-), 23.07 (NC-C-CH2-), 18.25 (=C-CH3), 7.54 (CH2-CH3). Anal. Calcd for C10H14N2OS: C, 57.11; H, 6.71; N, 13.32. Found: C, 57.28; H, 6.70; N, 13.29.
5-Methyl-3-(thiophene-2-carbonyl)-2,3,4,7-tetrahydro-1,4-thiazepine-6-carbonitrile (
11e): Yield 58%. Colorless solid, mp 138 °C. IR (KBr): 3344, 2185, 1652, 1602, 1481, 1408, 1260, 1061, 859, 839, 734 cm-1. 1H NMR (300 MHz, CDCl3): δ = 7.85-7.80 (m, 2 H, =CH-CH=), 7.27-7.22 (m, 1 H, S-CH=), 5.46-5.41 (m, 1 H, CH), 5.30 (br s, 1 H, NH), 4.31 (d, J = 15.7 Hz, 1 H, CN-C-CHH), 3.36 (dd, J = 13.5 and 2.4 Hz, 1 H, S-CHH), 3.08 (dd, J = 13.5 and 3.2 Hz, 1 H, S-CHH), 3.05 (d, J = 15.7 Hz, 1 H, CN-C-CHH), 2.16 (s, 3 H, CH3). 13C NMR (75 MHz, CDCl3): δ = 187.95 (C=O), 158.08 (=C-NH), 139.35 (=C-S), 136.02 (S-CH=), 133.23 (CO-C=CH), 128.77 (-CH=CH-S), 122.20 (C≡N), 78.67 (=C-CN), 61.27 (NH-CH-CO), 36.15 (-CH2-S), 28.52 (S-CH2-C=), 22.42 (CH3). Anal. Calcd for C12H12N2OS2: C, 54.52; H, 4.58; N, 10.60. Found: C, 54.69; H, 4.57; N, 10.57.
17 Deposition number CCDC 253714.
18 As an example, the specific rotation of 12c varied from [α]D
20 -131 (c 0.62, CHCl3) to [α]D
20 0 (c 0.44, CHCl3).